Show simple item record

dc.contributor.authorBarisic, Ien_US
dc.contributor.authorBoban, Len_US
dc.contributor.authorAkhmedzhanova, Den_US
dc.contributor.authorBergman, JEHen_US
dc.contributor.authorCavero-Carbonell, Cen_US
dc.contributor.authorGrinfelde, Ien_US
dc.contributor.authorMaterna-Kiryluk, Aen_US
dc.contributor.authorLatos-Bieleńska, Aen_US
dc.contributor.authorRandrianaivo, Hen_US
dc.contributor.authorZymak-Zakutnya, Nen_US
dc.contributor.authorSansovic, Ien_US
dc.contributor.authorLanzoni, Men_US
dc.contributor.authorMorris, JKen_US
dc.date.accessioned2018-06-29T10:51:11Z
dc.date.available2018-05-08en_US
dc.date.issued2018-09en_US
dc.date.submitted2018-06-05T15:46:25.129Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/41404
dc.description.abstractBeckwith Wiedemann syndrome is a complex developmental disorder characterized by somatic overgrowth, macroglossia, abdominal wall defects, neonatal hypoglycemia, and predisposition to embryonal tumors. We present epidemiological and clinical aspects of patients with Beckwith Wiedemann syndrome diagnosed prenatally or in the early years of life, using data from EUROCAT (European Surveillance of Congenital Anomalies) registries. The study population consisted of 371 cases identified between January 1990 and December 2015 in 34 registries from 16 European countries. There were 15 (4.0%) terminations of pregnancy after prenatal detection of severe anomaly/anomalies, 10 fetal deaths (2.7%), and 346 (93.3%) live-births. Twelve (3.6%) of the 330 live-births with available information on survival died in the first week of life, of those eleven (91.6%) were preterm. First-year survival rate was 90.9%. Prematurity was present in 40.6% of males and 33.9% of females. Macrosomia was found in 49.2% and 43.3% of preterm males and females, respectively. Of term newborns, 41.1% of males and 24% of females were macrosomic. Out of 353 cases with known time of diagnosis, 39.9% were suspected prenatally, 36.3% at birth, 7.6% were diagnosed in the first week of life, and 16.2% in the first year of life. The mean gestational age at prenatal diagnosis by obstetric ultrasound was 19.8 ± 6.2 (11-39) gestational weeks. The mean prenatal diagnosis of cases where parents opted for termination of pregnancy was 15.3 ± 2.4 (11-22) gestational weeks, and the mean gestational age at termination was 19.3 ± 4.1 (13-26) gestational weeks. The prenatal detection rate was 64.1% (141/220) with no significant change over time. There were 12.7% of familial cases. The study confirmed the association of assisted reproductive technologies with Beckwith Wiedemann syndrome, as 7.2% (13/181) of patients were conceived by one of the methods of assisted reproductive technologies, which was three times higher compared to the general population of the countries included in the study. Twin pregnancies of undetermined zygosity were recorded in 5.7% (21/365) cases, and were on average three to four times more common than in European countries that participated in the study. The estimated mean prevalence of classical Beckwith Wiedemann syndrome in Europe was 3.8 per 100,000 births or 1:26,000 births.en_US
dc.format.extent499 - 507en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofEur J Med Geneten_US
dc.rights© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectBeckwith Wiedemann syndromeen_US
dc.subjectCongenital anomaliesen_US
dc.subjectEpidemiologyen_US
dc.subjectEuropeen_US
dc.subjectPrenatal diagnosisen_US
dc.subjectAdulten_US
dc.subjectBeckwith-Wiedemann Syndromeen_US
dc.subjectEuropeen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectInfant, Newbornen_US
dc.subjectMaleen_US
dc.subjectPregnancyen_US
dc.subjectPregnancy Outcomeen_US
dc.subjectUltrasonography, Prenatalen_US
dc.titleBeckwith Wiedemann syndrome: A population-based study on prevalence, prenatal diagnosis, associated anomalies and survival in Europe.en_US
dc.typeArticle
dc.identifier.doi10.1016/j.ejmg.2018.05.014en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29753922en_US
pubs.issue9en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume61en_US
dcterms.dateAccepted2018-05-08en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record